ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CytRx Announces Director Election Results from 2021 Annual Meeting of Stockholders
July 30, 2021CytRx Corporation (OTCQB: CYTR) today announced that based on results from its 2021 Annual Meeting of Stockholders (the "Annual Meeting"), both of the Company's Class III director candidates have been elected to the Board of Directors (the "Board"). -
CytRx Begins Aldoxorubicin Phase 2 Study
May 27, 2020CytRx highlighted that ImmunityBio and NantKwest announced the initiation of a Phase 2 randomized, two-cohort, open-label study for first and second-line treatment of locally advanced or metastatic pancreatic cancer (QUILT-88). -
CytRx Announces Patent Issued for Aldoxorubicin in the Treatment of Brain Cancer
May 10, 2019CytRx Announces Patent Issued for Aldoxorubicin in the Treatment of Brain Cancer.
Pharma Sources Insight January 2025
